Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Delcath Systems Inc.

    NASDAQ: DCTH · Real-Time Price · USD
    16.35
    -0.52 (-3.08%)
    At close: Jun 06, 2025, 3:59 PM
    16.38
    0.18%
    After-hours: Jun 06, 2025, 04:04 PM EDT
    -3.08%
    Bid 15.43
    Market Cap 569.41M
    Revenue (ttm) 52.21M
    Net Income (ttm) -14.21M
    EPS (ttm) -0.45
    PE Ratio (ttm) -36.33
    Forward PE 25.61
    Analyst Strong Buy
    Ask 17.41
    Volume 353,504
    Avg. Volume (20D) 494,200
    Open 16.94
    Previous Close 16.87
    Day's Range 16.24 - 17.35
    52-Week Range 6.42 - 18.23
    Beta 0.93

    About DCTH

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol DCTH
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for DCTH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 weeks ago
    -6.32%
    DCTH stock has given up its prior gain. Delcath Sy... Unlock content with Pro Subscription
    2 weeks ago
    -6.32%
    Delcath Systems shares are trading higher after the company issued FY25 guidance and provided business updates.
    news image

    3 days ago · zacks.com

    Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should Know

    Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.

    news image

    1 week ago · zacks.com

    Wall Street Analysts Predict a 48.69% Upside in Delcath Systems (DCTH): Here's What You Should Know

    The average of price targets set by Wall Street analysts indicates a potential upside of 48.7% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, th...

    news image

    1 week ago · zacks.com

    Here's Why Momentum in Delcath Systems (DCTH) Should Keep going

    Delcath Systems (DCTH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

    news image

    2 weeks ago · businesswire.com

    Delcath Systems Issues Full Year 2025 Guidance

    QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic liver cancer...

    news image

    2 weeks ago · seekingalpha.com

    Delcath Systems: Q1 Earnings Show A Growth Spurt And Switch To Execution

    Delcath's commercial execution post-HEPZATO launch has driven impressive revenue growth, positive cash flow, and a shift from speculative to established biotech. Q1 earnings beat expectations with 530...

    news image

    3 weeks ago · businesswire.com

    Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference

    QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced tha...

    news image

    4 weeks ago · businesswire.com

    Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of t...

    news image

    4 weeks ago · seekingalpha.com

    Delcath Systems, Inc. (DCTH) Q1 2025 Earnings Call Transcript

    Delcath Systems, Inc. (NASDAQ:DCTH ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants David Hoffman - General Counsel, Corporate Secretary & Chief Compliance Officer Gerard...

    news image

    4 weeks ago · zacks.com

    Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates

    Delcath Systems, Inc. (DCTH) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to loss of $0.43 per share a year ago.

    news image

    4 weeks ago · businesswire.com

    Delcath Systems Reports First Quarter 2025 Results and Business Highlights

    QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic liver cancer...

    Add to Watchlist